The new nomenclature makes sense because ST-elevation MI (STEMI), non-ST-elevation MI (NSTEMI), and unstable angina have overlapping clinical presentations and call for similar evaluation and ...

Two treatment pathways have emerged for treating UA/NSTEMI patients ... For low risk patients, with possible unstable angina (e.g., without ECG changes or troponin elevations), an initially ...

Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina who are clinically unstable have coronary angiography (with follow-on percutaneous coronary intervention [PCI] if ...

The committee also suggests that the reversible non-thienopyridine P2Y12 receptor antagonist ticagrelor may play a future role in patients with unstable angina/NSTEMI based on results from the PLATO ...

Notably, unstable angina and non-ST-elevation myocardial infarction (NSTEMI), a type of heart attack, are similar conditions. In each condition, a plaque rupture has occurred in a coronary artery ...

An NSTEMI is diagnosed when your EKG does not show the type of abnormality seen in a STEMI but your blood tests show that your heart is stressed. Unstable angina. This is the least severe type of ACS.

Adults with non-ST-segment-elevation myocardial infarction (NSTEMI) or unstable angina are assessed for their risk of future adverse cardiovascular events using an established risk scoring system that ...

Despite the presence of a taxpayer-funded healthcare system in Denmark, social inequality in case fatality is observed in patients with NSTEMI and unstable angina, according to a study published ...

Clopidogrel, for instance, is FDA-approved for the medical treatment of unstable angina (UA)/non-ST-segment elevation myocardial infarction (NSTEMI). Clopidogrel, when mixed with aspirin, has earlier ...

a certain pattern on an electrocardiogram following a heart attack] and 15,459 with unstable angina/non–STEMI [UA/NSTEMI]), of whom 10,613 (17.1 percent) had diabetes. The researchers found that ...

The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) recently reviewed pivotal trials of the last 5 years and released an update to the 2002 UA/NSTEMI ...